Development of a novel conditional knockdown mouse based on YB-1 protein degradation

Area of Science:

• Biotechnology
• Genetics
• Molecular Biology

Background:

• Effective animal disease models are crucial for understanding pathogenesis and developing therapies.
• Existing methods like knockout and conditional genetically engineered mouse models have limitations such as embryonic lethality and low efficiency.
• The Y-box binding protein 1 (YB-1) is a cell survival factor implicated in various diseases and is widely expressed during development.

Purpose of the Study:

• To create a novel conditional knockdown mouse model for dynamic analysis of gene function.
• To establish a system for direct control of protein degradation using a destabilizing domain (DD) and a ligand.
• To investigate the role of YB-1 in disease pathogenesis through a conditional knockdown approach.

Main Methods:

• Development of a transgenic mouse model (YB1-DD) where the YB1 gene is fused with a destabilizing domain (DD).
• Utilizing trimethoprim (TMP) as a ligand to block the proteasomal degradation of DD-tagged proteins.
• Establishing a conditional knockdown system by administering TMP to YB1-DD mice.

Main Results:

• The YB1-DD mouse model demonstrated dose-dependent regulation of YB-1 protein levels by TMP.
• The conditional knockdown was effective in YB1 heterozygous mice, allowing for precise control over YB-1 expression.
• The model enables direct manipulation of protein degradation, offering a new strategy for gene function studies.

Conclusions:

• The developed YB1-DD mouse model represents a novel and functional conditional knockdown system.
• This model allows for direct control over protein degradation, overcoming limitations of existing genetic engineering techniques.
• The YB1-DD mouse holds significant potential as a versatile disease model for dynamic analysis and therapeutic development.